United States· US:61269-404_f57fbea0-8124-4877-b7c6-f1b154d8c659

DROXIA

A medicinal product containing hydroxyurea, registered in United States by H2-Pharma LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDROXIAATC—REGISTER NO.US:61269-404_f57fbea0…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HYDROXYUREA
Manufacturer
H2-Pharma LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6126940460
    60 CAPSULE in 1 BOTTLE (61269-404-60)
  • ndc11
    61269-404-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hydroxyurea in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxyurea products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Ardjaq, Hydroxycarbamid Devatis
  • Belgium · Hydrea
  • Bulgaria · Хидреа
  • Cyprus · Hydreasyn
  • Czechia · Litalir
  • Germany · Ardjaq, Hydroxycarbamid 1 A Pharma
  • Denmark · Hydroxyurea Medac, Oribamide
  • Estonia · Hydrea
  • Spain · Hidroxicarbamida Hikma, Hidroxicarbamida Medac
  • Finland · Hydrea, Hydroxyurea Medac
  • France · Hydrea, Hydroxycarbamide Arrow
  • United Kingdom (Northern Ireland) · Hydrea, Hydroxycarbamide
  • Greece · Hydreasyn
  • Croatia · Litalir, Xybaid
  • Hungary · Hydroxycarbamide Pharmacenter, Litalir
  • Ireland · Hydrea
  • Iceland · Hydroxyurea Medac, Siklos
  • Italy · Idrossicarbamide Aurobindo, Onco Carbide
  • Liechtenstein · Siklos
  • Lithuania · Hydrea
  • Luxembourg · Hydrea, Hydroxycarbamid Devatis
  • Latvia · Hydrea
  • Malta · Hydroxycarbamide Eugia
  • Netherlands · Hydroxycarbamide Devatis, Hydroxycarbamide Eugia
  • Norway · Hydroxyurea Medac, Oribamide
  • Poland · Hydroxycarbamid Eugia, Hydroxycarbamid Teva
  • Portugal · Hidroxicarbamida Generis, Hidroxicarbamida Hikma
  • Romania · Hydrea
  • Sweden · Hydrea, Hydroxyurea Medac
  • Slovenia · Hidroksisečnina Aptapharma, Litalir
  • Slovakia · Hydroxykarbamid Medac, Xybaid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec59b63d-d6c2-4c28-8a9e-a6d3c9ce19a6
GET /v1/drugs/ec59b63d-d6c2-4c28-8a9e-a6d3c9ce19a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "400",
  "substance": "HYDROXYUREA",
  "productndc": "61269-404",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA016295",
  "marketing_category": "NDA"
}

See everything about hydroxyurea.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.